Background. We present an analysis of increasing rates of invasive group A streptococci (iGAS) over a 15-year period in Alberta, Canada.
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Confirmed iGAS cases were defined as the identification of GAS from any normally sterile site including blood, CSF, brain, other sterile organs, deep tissues, joints, etc. (https://open.alberta.ca/ publications/streptococcal-disease-group-a-invasive). Probable iGAS cases were defined as severe invasive disease in the absence of another etiology with isolation of GAS from a nonsterile site.
Once iGAS isolates were initially identified by a diagnostic microbiology laboratory, Public Health officials were informed, and the clinical data were collected as per routine notifiable disease requirements by trained public health nurses using a notifiable disease reporting form [15] . These data were captured in the Communicable Disease Reporting System (CDRS), held at the Ministry of Health, Alberta. The definitions used to capture clinical presentation of disease are defined in the Alberta Health Notifiable Disease Manual [16] . Clinical data from CDRS were linked with laboratory data from the Provincial Laboratory for Public Health (ProvLAB) using a Unique Lifetime identifier for each patient. Case fatality rates (CFRs) were captured if the case had died at the time the notifiable disease report form was completed. All notifiable disease reports were completed within 30 days of the initial notification of an iGAS case.
iGAS Isolates and emm Typing iGAS isolates are required to be submitted to ProvLAB for emm typing. The methodology used to type iGAS isolates from 2003 to September 2006 was via a previously described serological typing assay, and from October 2006 to 2017 by emm typing, which was done by DNA sequencing of the M serotype-specific region of the emm gene [13, 17, 18] .
Statistical Analysis
Alberta population estimates from 2003-2017 were extracted from the online Interactive Health Data Application (IHDA) database [14] . We estimated incidence rates by year of diagnosis, age group, and health zone (of patient residence at the time of diagnosis) over the study period. Incidence rates were calculated for each characteristic as number of cases per 100 000 persons per year. The Cochran-Armitage trend test was used to test for linear trend of risk factors over time. Data were analyzed using SAS 9.3 (SAS Institute Inc., Cary, NC) and graphed using OriginLab software 2018 (OriginLab Corporation, Northampton, MA).
RESULTS

Incidence
From 2003 to 2017, there were 3551 cases of both confirmed and probable iGAS reported. Probable cases were 1.2% (43 cases). Table 1 shows that the incidence of iGAS in Alberta steadily increased over the 15 years surveyed. The overall age-standardized incidence was 4.24 in 2003 and increased to 10.24 in 2017. Increasing incidence rates over the 15 years surveyed are more evident in adults (age 20 years and older) than children (age 0-19 years) ( Figure 1 ). Overall incidence was highest at the extremes of age, with individuals <1 year of age having an incidence of 9.69 and individuals' ≥60 years having an incidence of 11.15 ( Figure 2 ).
Case Demographics, Clinical Presentation, and Risk Factor Analysis
Of the 3551 cases, gender was identified for 3549; 2051 cases (57.79%) were male. The mean age was 44.86 years. The overall age-standardized CFR was 5.11% (226 deaths/3551 cases) ( Table 1 ). The year 2010 had the lowest percentage CFR (4.12%), and 2012 had the highest (8.85%) ( Table 1 ). The CFR in males was 5.75%, and for females it was 7.21% (chi-square = 3.08; P = .08). The highest CFR occurred in those cases age ≥60 years (12.97%; 127 deaths) ( Figure 2 ). The incidence was higher in males (7.20) than females (5.42) overall. The most common clinical diagnosis was septicemia/bacteremia, at >40% of cases, followed by the skin-associated infections cellulitis (17.25%) and soft tissue infection (12.31%) ( Table 2 ). Table 3 shows risk factor data presented in 3-year periods. Diabetes, hepatitis C, nonsurgical wounds, addiction, alcohol abuse, drug use, and homelessness (P < .05) were commonly found risk factors that trended upward over the 15 years surveyed. No identified risk factor significantly trended downward ( [19] . Of the 65 emm types identified, 3 emm types emerged, with higher rates in 2017 than the previous 14 years. These were emm74, 76, and 81. In addition, emm101 showed higher case numbers starting in 2015 than the years before. With respect to overall numbers of cases, emm1, emm28, and emm59 accounted for more than one-third (34.33%) of all cases typed. The most common emm type was emm1, accounting for 19.28% of the total cases typed ( Table 4 ). The percentage of emm1 typed cases compared with the overall typed case numbers by year ranged from a low of 9.43% (2006) In the last year of the survey (2017), 32 different emm types were identified, with emm1 accounting for 20% ( Table 4 ). The next most common emm types in order of prevalence for 2017 were 74 and 101, followed by 59. Together, these 4 emm types (1, 74, 101, and 59) accounted for 46.58% of the iGAS cases in 2017 ( Figure 3 and Table 4 ). Table 5 shows the distribution of iGAS cases according to clade, emm type, emm cluster, and clinical presentation. The distribution of cases between clades X and Y is equal in case numbers, at 50% each. Four cluster types, A-C3, D4, E4, and E6, accounted for the majority of septicemia/bacteremia (71%), cellulitis (72%), soft tissue infections (70%), pneumonia (68.9%), and necrotizing fasciitis (77%) iGAS cases. For STSS, cluster types A-C3, A-C5, E4, and E6 were the most common, accounting for 72.4% of iGAS cases that occurred during the period surveyed. Figure 4 displays the number of cases identified by month for each year surveyed. Presenting the 15 years surveyed as 1 calendar year shows that a peak in iGAS cases generally occurred in the winter months of January and December, with a low in the month of September (Figure 4 ).
Seasonality
DISCUSSION
We have provided a report on 15 years of iGAS disease in Alberta, Canada, during which incidence rose from 4.24 (2003) to 10.24 (2017) . Recent surveillance from the Active Bacterial Core surveillance program (a program representing approximately 10% of the US population) also documented a rise in rates [20] . This program showed an incidence of 3.4 in 2012 rising to 5.8 in 2016, suggesting that increases in iGAS are occurring throughout North America [20] . Table 3 that trended upward over the 15 years surveyed for iGAS were diabetes, hepatitis C, nonsurgical wounds, drug abuse, alcohol abuse, addiction, and homelessness. These risk factors have been described as key players for patients with iGAS infections in other surveys [22] [23] [24] . For example, in the large emm59 outbreak that occurred in western Canada from 2006 to 2009, alcohol abuse, illicit drug use, and homelessness were considered significant risk factors [22] .
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unlikely the only reason for the increase in emm1 seen, especially for 2017. It is likely that the increase is multifactorial, involving both the GAS strain and the affected population having significant risk factors for the disease.
The second most common emm types in 2017 were emm74 and emm101. Data from the Centers for Disease Control and Prevention's Active Bacterial Core surveillance program (2010) (2011) (2012) (2013) (2014) (2015) (2016) show that emm74 was documented once from a case in Maryland in 2010 and that emm101 has not been documented [20] . Although emm74 increases were not evident in the United States in the years surveyed, increases in emm74 have been reported in Ontario and other parts of Canada recently [28] .
emm101 was first identified in Alberta in 2009, with the highest number of cases in 2017. In Canada, Athey et al. documented emm101 as 1 of the 6 most prevalent emm types from 2011 to 2013, identified from cases in Thunder Bay, Ontario [23] . The recent BCCDC report for 2017 listed emm101 as the third most common emm type in British Columbia, at 11% [21] .
Increased rates of emm59 cases in Canada were first described in 2006, and since this outbreak, increased rates of emm59 cases have been reported in the United States (MT, WY, AZ, NM) [22, 29, 30] . In the description of the emm59 outbreak in Canada, emm59 cases were associated with alcohol abuse, illicit drug use, and homelessness [22] . Based on the risk factors described in this report, which are similar to the risk factors for the emm59 outbreak in 2006-2009, it would not be surprising to see emm59 case numbers rise again.
Potential GAS vaccines have focused on M protein as a vaccine component. For 1 vaccine, investigators used the variable portion of the M protein and incorporated 30 M types in 1 formulation [19] . Multivalent vaccines have the potential problem that M types can change over time, resulting in lack of coverage for specific circulating emm types. This could potentially be addressed through development of emm cluster-based vaccines as there is a limited number of cluster types, in comparison with the number of emm types [31] . In our survey, a breakdown of emm types by cluster type suggests that a vaccine for Alberta should encompass members of 5 cluster types, A-C3, D4, E3, E4, and E6, out of the 19 cluster types identified. These 5 cluster types constitute close to 80% of the emm types that were identified in our survey.
Although this survey provides important information regarding iGAS disease in Alberta, there are limitations. The described survey is retrospective and not prospective. A retrospective study does not allow investigators to go back to cases and interview patients for information that may not have been collected at the onset. Also, a passive surveillance system was used to collect the data; therefore, the possibility exists that cases may not have been reported. Another limitation is that not all cases had a GAS isolate for typing (87% were typed). However, having close to 90% of isolates emm-typed over a 15-year period still provides useful information regarding circulating emm types.
In summary, rates of iGAS disease in Alberta, Canada, have risen since 2003, reaching >10/100 000 in 2017. No single emm type alone can be attributed to the higher rates but rather a collection of common and new emerging emm types are evident. Another driver contributing is likely the growing number of marginalized and homeless people. 
